Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Person cyswllt: Anila Kreku
E-bost: anila.kreku@dhsc.gov.uk
NUTS: UKI32
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Cyfeiriad proffil y prynwr: https://www.gov.uk/government/organisations/department-of-health-and-social-care
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
DHSC: GPH: Fleming Fund Managing Agent - Market Engagement
II.1.2) Prif god CPV
75211200
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement.
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 1.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
The Fleming Fund supports Lower Middle Income Countries (LMICs) to tackle the deadly global impact of antimicrobial resistance (AMR) by improving laboratory capacity, diagnosis and building sustainable surveillance systems, taking a One Health approach. DHSC anticipates needing a Management Agent to deliver the aims of phase III of the Fleming Fund.<br/><br/>This is the first in a series of market engagement events to engage with the market on the anticipated Phase III procurement. <br/><br/>There Authority will host a will be a market engagement day on 20 March 2025 from 10:00 - 12:00. <br/>Interested attendees are required to RSVP by 17:00 on 18th March 2025.
II.2.14) Gwybodaeth ychwanegol
This will be a virtual event. <br/><br/>Clarification questions are permitted until 14th March 2025.<br/><br/>The budget for Phase III of the Fleming Fund is yet to be finalised, it is anticipated that the budget will be similar to Phase I and Phase II, however the Authority will confirm at later market engagement events.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
01/09/2025
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section VI: Gwybodaeth ategol
VI.5) Dyddiad anfon yr hysbysiad hwn
21/02/2025